Multi-omics reveals branched chain amino acid signatures as prognostic factors for immunotherapy efficacy in non-small cell lung cancer

被引：0
|
作者：
Dai, L. [1 ]
Lou, N. [2 ]
Yuankai, S. [2 ]
Han, X. [3 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Clin Lab Dept, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp,Med Oncol, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Clin Pharmacol Res Ctr, Dongdan Campus, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
624P
引用
收藏
页码：S1629 / S1629
页数：1
相关论文
共 50 条
  • [31] Immunotherapy in metastatic non-small cell lung cancer: EPSILoN as a prognostic score
    Valente, M. C. Alves
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Sousa, C.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] COPD and pulmonary emphysema as prognostic factors in patients with non-small cell lung cancer receiving immunotherapy
    Aineto, Marcos Becerra
    Martinez, Aitor Azkarate
    Coma, Amanda Iglesias
    Budau, David
    Parreira, Ana Sofia De Freitas Matos
    Font, Esther Martinez
    Sanchez, Maria Belen Nunez
    Roig, Jaume Sauleda
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [33] Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
    Wang, Chengdi
    Li, Jingwei
    Chen, Jingyao
    Wang, Zhoufeng
    Zhu, Guonian
    Song, Lujia
    Wu, Jiayang
    Li, Changshu
    Qiu, Rong
    Chen, Xuelan
    Zhang, Li
    Li, Weimin
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [34] Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
    Yimin Wang
    Chuling Li
    Zimu Wang
    Zhaofeng Wang
    Ranpu Wu
    Ying Wu
    Yong Song
    Hongbing Liu
    BMC Medicine, 20
  • [35] Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
    Wang, Yimin
    Li, Chuling
    Wang, Zimu
    Wang, Zhaofeng
    Wu, Ranpu
    Wu, Ying
    Song, Yong
    Liu, Hongbing
    BMC MEDICINE, 2022, 20 (01)
  • [36] To Construct Multi-Omics Modelfor Predicting Prognosis of Definitive Chemoradiotherapyin Locally Advanced Non-Small Cell Lung Cancer
    Li, L.
    Song, X.
    Liu, N.
    Zhou, T.
    Yuan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S567 - S567
  • [37] Estrogen receptor α and β are prognostic factors in non-small cell lung cancer
    Kawai, H
    Ishii, A
    Washiya, K
    Konno, T
    Kon, H
    Yamaya, C
    Ono, I
    Minamiya, Y
    Ogawa, J
    CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5084 - 5089
  • [38] Prognostic Factors for Brain Metastasis in Non-Small Cell Lung Cancer
    Duma, Narjust
    Sanchez, Laysa
    Miranda, Claudia
    Glisch, Chad
    Abu-Ihweij, Khaleb
    Zhang, Shijia
    Osorio, Carlos
    Listo, Matthew
    Harper, Harry D.
    Gutierrez, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S535 - S535
  • [39] Molecular prognostic factors in resectable non-small cell lung cancer
    Vielh, P
    Spano, JP
    Grenier, J
    Le Chevalier, I
    Soria, JC
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 53 (03) : 193 - 197
  • [40] PROGNOSTIC FACTORS FOR ADVANCED NON-SMALL CELL LUNG CANCER IN JAPANESE
    Mizutani, Tomonori
    Takeda, Yuichiro
    Naka, Go
    Horio, Yuko
    Fujita, Yu
    Sugiyama, Eri
    Yagishita, Shigehiro
    Ishi, Satoshi
    Hirano, Satoru
    Kobayashi, Nobuyuki
    Kudo, Kouichiro
    ANNALS OF ONCOLOGY, 2010, 21 : 25 - 25
12345